Oil for Life to Balance omega-3 polyunsaturated fatty acids ... - Oil4Life
Oil for Life to Balance omega-3 polyunsaturated fatty acids ... - Oil4Life
Oil for Life to Balance omega-3 polyunsaturated fatty acids ... - Oil4Life
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>omega</strong>-3 has been associated with increased risks of cardiovascular disease,<br />
neurodegenerative disorders and some cancers, including carcinoma of the breast. The<br />
observed increased risk of breast cancer in Japanese women over the past four decades<br />
correlates with an increased imbalance of dietary <strong>omega</strong>-6 <strong>to</strong> <strong>omega</strong>-3 ratio.<br />
The membrane of our trillions of cells physically separates the intracellular components from<br />
the extracellular environment. The movement of water, nutrients and waste across the<br />
membrane can be either passive or active (energy required). The arrangement of hydrophilic<br />
heads and hydrophobic tails in the lipid bilayer allow the cell <strong>to</strong> control the movement of<br />
substances via transmembrane protein complexes such as pores and gates. The <strong>fatty</strong> acid<br />
present in membrane lipids come from the diet. Phospholipids are main components of cell<br />
membrane in our trillions of cells with a hydrophilic head and generally one saturated <strong>fatty</strong><br />
acid and one <strong>polyunsaturated</strong> <strong>fatty</strong> acid (<strong>omega</strong>-6 or <strong>omega</strong>-3) as the hydrophobic tails. The<br />
length and the degree of unsaturation of <strong>fatty</strong> <strong>acids</strong> chains have a profound effect on<br />
membranes fluidity. Unsaturated lipids create a kink, preventing the <strong>fatty</strong> <strong>acids</strong> from packing<br />
tightly <strong>to</strong>gether, thus increasing the fluidity of the membrane and facilitating the exchanges<br />
of substances. Human cells constantly receive signals from other cells and from the<br />
environment, which they perceive, interpret and respond <strong>to</strong> with appropriate metabolic or<br />
physiological changes.<br />
An unbalanced ratio of mega-6 / <strong>omega</strong>-3 in cell membrane phospholipids may create a proinflamma<strong>to</strong>ry<br />
climate within the cells. Inflammations are a key cause of pain. Phospholipase<br />
A2 frees EPA (<strong>omega</strong>-3) and aracidonic acid (AA; <strong>omega</strong>-6) located in the 2 nd position of<br />
the phospholipid molecule. The released AA and EPA are further oxidized by specific<br />
enzyme <strong>to</strong> eicosanoids, signaling molecules called prostaglandins, leukotrienes,<br />
thromboxane and prostacyclins. These hormone-like compounds are involved in tissue<br />
damage, inflammation and pain. The enzymatic releases of arachidonic acid (AA - <strong>omega</strong>-6)<br />
from membrane phospholipids enhance the synthesis of eicosanoids of the 2 and 4 series.<br />
These eicosanoids are pro-inflamma<strong>to</strong>ry products that in turn create pain, which is<br />
recognised by pain recep<strong>to</strong>rs and transmitted <strong>to</strong> the brain. On contrary the release of<br />
eicosapentaenoic acid (EPA – <strong>omega</strong>-3) from membrane phospholipids enhance the<br />
synthesis of eicosanoids of the 3 and 5 series being less inflamma<strong>to</strong>ry. The networks of<br />
controls that depend upon eicosanoids are among the most complex in the human body. They<br />
exert complex control over inflammation and immunity systems, and are messengers in the<br />
central nervous system.<br />
Menstrual pain is the most common gynecological complaint among female adolescents and<br />
young women. The high intake of <strong>omega</strong>-6 <strong>fatty</strong> <strong>acids</strong> in the western diet is reflected in the<br />
cell membrane phospholipids. Due <strong>to</strong> progesterone withdrawal be<strong>for</strong>e menstruation<br />
arachidonic acid (<strong>omega</strong>-6) are released, and a cascade of eicosanoids is initiated in the<br />
uterus. The inflamma<strong>to</strong>ry response mediated by these eicosanoids produces both cramps and<br />
systemic symp<strong>to</strong>ms such as nausea, vomiting, bloating and headaches, including ischemia,<br />
pain and systemic symp<strong>to</strong>ms of dysmenorrhoea. EPA and DHA, as in Oli4<strong>Life</strong> <strong>Balance</strong>,<br />
compete with arachidonic acid <strong>for</strong> the production of eicosanoids. In the uterus, this<br />
competitive interaction between <strong>omega</strong>-3 and <strong>omega</strong>-6 <strong>fatty</strong> <strong>acids</strong> may result in the<br />
production of less potent eicosanoids and may lead <strong>to</strong> a reduction in the systemic symp<strong>to</strong>ms<br />
of dysmenorrhea.<br />
The arachidonic acid metabolism is also altered in psoriasis. Proinflamma<strong>to</strong>ry leukotrienes<br />
(LTB4) are markedly produced in the psoriatic lesions. Fish oil and <strong>omega</strong>-3 <strong>fatty</strong> <strong>acids</strong> are<br />
2